BMEA

Quote

Short

News

Articles

Message Board

Biomea Fusion Inc. (NASDAQ : BMEA ) News

Biomea Fusion Inc. (NASDAQ: BMEA) News Releases

BMEA News Releases

April 27, 2026 05:37:38 pm

GlobeNewswire

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

March 31, 2026 07:00:00 am

GlobeNewswire

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies

March 31, 2026 01:22:02 am

SeekingAlpha

Biomea Fusion, Inc. (BMEA) Discusses Menin Inhibition Mechanism and Therapeutic Potential in Diabetes Transcript

March 30, 2026 05:02:42 pm

Zolmax

Biomea Fusion Details Icovamenib Diabetes Milestones, Teases BMF-650 Obesity Readouts

March 30, 2026 03:22:23 pm

SeekingAlpha

Biomea Fusion, Inc. (BMEA) Discusses Phase I Data and Clinical Potential of Oral GLP-1 Receptor Antagonist for Obesity Transcript

March 24, 2026 04:37:57 pm

SeekingAlpha

Biomea Fusion GAAP EPS of -$1.18 beats by $0.36

March 24, 2026 04:05:00 pm

GlobeNewswire

Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights

March 14, 2026 04:30:00 am

GlobeNewswire

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

January 23, 2026 11:24:07 am

SeekingAlpha

JPMorgan's top short ideas for Q1: FTNT, TXT, IMO and more

January 15, 2026 02:35:59 am

SeekingAlpha

Biomea Fusion, Inc. (BMEA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Back to Start	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account